However, within the subgroup of patients with metastatic disease treated with paclitaxel containing chemotherapy, disease specific survival was significantly poorer in those patients with high compared to normal stathmin (p = 0.03, Fig. 5b). The gene discussed is STMN1; the disease is metastatic neoplasm.